The Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Post-Diagnosis: Results from an International Survey
Jonathan D. Santoro, Gabrielle deFiebre, Julia Lefelar, Panayotes Demakakos, Danielle Hartigh, Magali Periquet, Khaleda Ahmadyar, Zara Morrison, Jacqueline Palace · 2026
Read The Patient Experience of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Post-Diagnosis: Results from an International Survey by Jonathan D. Santoro, Gabrielle deFiebre, Julia Lefelar, Panayotes Demakakos, Danielle Hartigh, Magali Periquet, Khaleda Ahmadyar, Zara Morrison, Jacqueline Palace (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13615204.txt.
Description
Jonathan Santoro and co-authors survey patients with a rare immune disease of the brain and spinal cord in this 2026 paper. The disease is driven by antibodies against a protein called MOG. Little was known about how patients fare after diagnosis or how happy they are with care.
The online survey drew two hundred sixty-one replies from twenty-seven countries in late 2024, covering adults and children. Many patients had stopped a preventive treatment, often over side effects or weak effect. Most reported trouble getting care, and many were unhappy with help for long-term symptoms or emotional support. Caregivers reported far heavier mental health strain than patients themselves. The authors call for better drugs and better support for families.
Catalog record
| CREATOR | Jonathan D. Santoro, Gabrielle deFiebre, Julia Lefelar, Panayotes Demakakos, Danielle Hartigh, Magali Periquet, Khaleda Ahmadyar, Zara Morrison, Jacqueline Palace |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |